» Articles » PMID: 26001595

High-throughput Sequencing Reveals Altered Expression of Hepatic MicroRNAs in Nonalcoholic Fatty Liver Disease-related Fibrosis

Overview
Journal Transl Res
Publisher Elsevier
Specialty Pathology
Date 2015 May 24
PMID 26001595
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that microRNAs (miRNAs), small, noncoding RNA molecules that regulate gene expression, may play a role in the regulation of metabolic disorders, including nonalcoholic fatty liver disease (NAFLD). To identify miRNAs that mediate NAFLD-related fibrosis, we used high-throughput sequencing to assess miRNAs obtained from liver biopsies of 15 individuals without NAFLD fibrosis (F0) and 15 individuals with severe NAFLD fibrosis or cirrhosis (F3-F4), matched for age, sex, body mass index, type 2 diabetes status, hemoglobin A1c, and use of diabetes medications. We used DESeq2 and Kruskal-Wallis test to identify miRNAs that were differentially expressed between NAFLD patients with or without fibrosis, adjusting for multiple testing using Bonferroni correction. We identified a total of 75 miRNAs showing statistically significant evidence (adjusted P value <0.05) for differential expression between the 2 groups, including 30 upregulated and 45 downregulated miRNAs. Quantitative reverse-transcription polymerase chain reaction analysis of selected miRNAs identified by sequencing validated 9 of 11 of the top differentially expressed miRNAs. We performed functional enrichment analysis of dysregulated miRNAs and identified several potential gene targets related to NAFLD-related fibrosis including hepatic fibrosis, hepatic stellate cell activation, transforming growth factor beta signaling, and apoptosis signaling. We identified forkhead box O3 and F-box WD repeat domain containing 7, E3 ubiquitin protein ligase (FBXW7) as potential targets of miR-182, and found that levels of forkhead box O3, but not FBXW7, were significantly decreased in fibrotic samples. These findings support a role for hepatic miRNAs in the pathogenesis of NAFLD-related fibrosis and yield possible new insight into the molecular mechanisms underlying the initiation and progression of liver fibrosis and cirrhosis.

Citing Articles

Predictive value of miR-582-5p for onset of sepsis-induced acute kidney injury and its functional role during disease development.

Zhao Y, Li Y, Su M, Cai X Cent Eur J Immunol. 2025; 49(4):383-392.

PMID: 39944255 PMC: 11811718. DOI: 10.5114/ceji.2024.145730.


Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.

Krause C, Britsemmer J, Bernecker M, Molenaar A, Taege N, Lopez-Alcantara N Elife. 2024; 12.

PMID: 39037913 PMC: 11262792. DOI: 10.7554/eLife.92075.


Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci.

Xu H, Gupta S, Dinsmore I, Kollu A, Cawley A, Anwar M medRxiv. 2024; .

PMID: 38903089 PMC: 11188121. DOI: 10.1101/2024.06.11.24308730.


Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells.

Khalifa O, Ouararhni K, Errafii K, Alajez N, Arredouani A Int J Mol Sci. 2023; 24(14).

PMID: 37511368 PMC: 10380891. DOI: 10.3390/ijms241411606.


MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.

Compagnoni C, Capelli R, Zelli V, Corrente A, Vecchiotti D, Flati I Int J Mol Sci. 2023; 24(11).

PMID: 37298191 PMC: 10252350. DOI: 10.3390/ijms24119239.


References
1.
Liang T, Liu C, Ye Z . Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. PLoS One. 2013; 8(11):e80774. PMC: 3829963. DOI: 10.1371/journal.pone.0080774. View

2.
Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A . MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res. 2009; 33(10):1704-10. PMC: 3753180. DOI: 10.1111/j.1530-0277.2009.01007.x. View

3.
Pogribny I, Starlard-Davenport A, Tryndyak V, Han T, Ross S, Rusyn I . Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest. 2010; 90(10):1437-46. PMC: 4281935. DOI: 10.1038/labinvest.2010.113. View

4.
Tian G, Tang Y, He P, Lv Y, Ouyang X, Zhao G . The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochem Biophys Res Commun. 2013; 443(2):428-34. DOI: 10.1016/j.bbrc.2013.11.109. View

5.
Wang J, Zhou W, Hu W, Zhou L, Wang S, Zhang S . Collagen/silk fibroin bi-template induced biomimetic bone-like substitutes. J Biomed Mater Res A. 2009; 99(3):327-34. DOI: 10.1002/jbm.a.32602. View